Tandem Diabetes Care (TNDM) Current Assets (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Current Assets came in at $887.1 million in Q1 2026, up 33.71% YoY from $663.4 million in Q1 2025, and up 43.51% on a QoQ basis from $618.1 million in Q4 2025.
Tandem Diabetes Care (TNDM) Current Assets (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Current Assets data on file, last reported at $887.1 million in Q1 2026.
- Quarterly Current Assets rose 33.71% year-over-year to $887.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $887.1 million (up 33.71% YoY) and the FY2025 annual result came in at $618.1 million, down 14.68% from the prior year.
- Current Assets improved to $887.1 million in Q1 2026, from $618.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $887.1 million in Q1 2026 to a low of $614.8 million in Q2 2025.
- A 5-year average of $747.8 million and a median of $752.8 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2025 — Current Assets fell 18.05% — and 2026, when it soared 33.71%.
- Tracing TNDM's Current Assets over 5 years: stood at $850.0 million in 2022, then declined by 12.0% to $748.0 million in 2023, then retreated by 3.14% to $724.5 million in 2024, then retreated by 14.68% to $618.1 million in 2025, then surged by 43.51% to $887.1 million in 2026.
- The last three Current Assets figures came in at $887.1 million (Q1 2026), $618.1 million (Q4 2025), and $616.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 804.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 804.64 Mn |
| Mar 31, 2026 | 887.10 Mn |
| Dec 31, 2025 | 618.14 Mn |
| Sep 30, 2025 | 616.94 Mn |
| Jun 30, 2025 | 614.82 Mn |
| Mar 31, 2025 | 663.44 Mn |
| Dec 31, 2024 | 724.49 Mn |
| Sep 30, 2024 | 752.83 Mn |
| Jun 30, 2024 | 733.39 Mn |
| Mar 31, 2024 | 735.19 Mn |
| Dec 31, 2023 | 747.99 Mn |
| Sep 30, 2023 | 758.14 Mn |
| Jun 30, 2023 | 764.30 Mn |
| Mar 31, 2023 | 757.92 Mn |
| Dec 31, 2022 | 849.98 Mn |
| Sep 30, 2022 | 834.30 Mn |
| Jun 30, 2022 | 835.04 Mn |
| Mar 31, 2022 | 818.46 Mn |
| Dec 31, 2021 | 811.52 Mn |
| Sep 30, 2021 | 754.95 Mn |